CATALYST FINANCIAL PARTNERS LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1927537 BOSTON, MA

Position in VRTX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$738,577

+$134,702 QoQ

Shares Held

1,654

+24.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

CATALYST FINANCIAL PARTNERS LLC holds $1,567,578 across 4 Biotechnology names. VRTX ranks #1 (47.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,654	$738,577
2	REGN	Regeneron Pharmaceuticals, Inc.	462	$356,959
3	DMAC	DiaMedica Therapeutics Inc.	38,457	$260,353
4	ABOS	Acumen Pharmaceuticals, Inc.	89,699	$211,689

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$738,577	1,654	+24.2%	Shares	Sole	2026-05-12
2025-12-31	$603,875	1,332	+19.6%	Shares	Sole	2026-02-04
2025-09-30	$436,286	1,114	-4.8%	Shares	Sole	2025-11-12
2025-06-30	$520,884	1,170	-14.0%	Shares	Sole	2025-08-14
2025-03-31	$659,840	1,361	+21.0%	Shares	Sole	2025-05-02
2024-12-31	$453,037	1,125	+3.6%	Shares	Sole	2025-01-30
2024-09-30	$505,076	1,086	+0.1%	Shares	Sole	2024-10-28
2024-06-30	$508,561	1,085	+6.6%	Shares	Sole	2024-07-25
2024-03-31	$425,534	1,018	+4.2%	Shares	Sole	2024-04-23
2023-12-31	$397,531	977	+3.8%	Shares	Sole	2024-02-07
2023-09-30	$327,223	941	+8.2%	Shares	Sole	2023-10-26
2023-06-30	$306,161	870	+16.2%	Shares	Sole	2023-08-02
2023-03-31	$235,987	749	—	Shares	Sole	2023-04-11
No filing history on record for this holder in this stock.